Yiwangyichuang: Shareholder Zhang Fan plans to reduce his shareholding by no more than 1%. Yiwangyichuang announced that shareholder Zhang Fan, who holds more than 5% of the company's shares, plans to reduce his shareholding by centralized bidding and/or block trading, and the number of shares to be reduced is no more than 2,369,400, accounting for 1.00% of the company's total share capital. The reduction period is from January 6, 2025 to April 4, 2025. The price range of reduction will be determined according to the market price and trading method at the time of reduction. The reason for Zhang Fan's reduction is based on his own capital demand, and the shares come from the shares issued before the initial public offering, the shares transferred due to equity distribution and the shares transferred by agreement.Lian Ping interprets the Central Economic Work Conference: The ups and downs of the stock market will be included in the adjustment function of the central bank in the future, and the Central Economic Work Conference will be held in Beijing from December 11 to 12. Regarding the exploration and expansion of the macro-prudential and financial stability functions of the central bank mentioned in the meeting, Lian Ping, president of the Guangdong Development Institute and chairman of the China Chief Economist Forum, explained that the ups and downs of the stock market will be included in the adjustment function of the central bank in the future. (CBN)Turkey says Ethiopia and Somalia will negotiate the Horn of Africa agreement.
Hongjiu Fruit: Jiang Zongying, the controlling shareholder and executive director, pledged 21 million H shares of the company. Hongjiu Fruit (06689) announced that the company had learned that Ms. Jiang Zongying, the controlling shareholder and executive director of the company, had pledged the company's shares on December 11, 2024. Because the company failed to return the relevant funds to the subscriber within the time limit stipulated in the termination agreement, Ms. Jiang pledged 21 million H shares of the company to the subscriber as the company's subsequent refund of the relevant funds to the subscriber.Kegong: Orban proposed to Putin a Christmas ceasefire between Russia and Ukraine. According to the latest news from AFP, peskov, press secretary of Russian President and spokesman of Kegong, said on Thursday (12th) that Hungarian Prime Minister Orban proposed to Russian President Putin the day before: a Christmas ceasefire between Russia and Ukraine. According to the report, peskov said that Russia submitted its "proposal" on the exchange of prisoners of war to the Hungarian Embassy in Russia that day, and Russia supported "Orban's efforts". (World Wide Web)Laimei Pharmaceutical Co., Ltd.: The controlling shareholder intends to transfer 23.43% of the shares by agreement. Laimei Pharmaceutical announced that Zhongheng Group, the controlling shareholder, intends to transfer 247 million shares of the company's unrestricted tradable A shares by public solicitation of the transferee, accounting for 23.43% of the company's total share capital, and the transfer price is not less than 4.42 yuan/share. If the share transfer is completed, the controlling shareholder and actual controller of the company may change.
South Korea's Seoul Composite Index rose to 1%.Gobi Venture Capital announced in Shanghai that it will launch a $50 million venture capital fund to support Pakistan's technology start-ups. On December 12th, at the Pakistan Investment Summit held in Shanghai, Gobi Venture Capital, an Asian venture capital company, officially announced the launch of a $50 million fund Techxila Fund II to support Pakistan's start-ups, focusing on high-potential industries such as financial technology, e-commerce logistics and supply chain, health technology and SaaS. Gobi Venture Capital also signed a memorandum of understanding with Punjab Bank (BoP). (First Financial Reporter Qian Tongxin)Tiankang Bio: Tiankang Bio (002100) announced on the evening of December 12 that Tiankang Bio (stock code: 874339), a holding subsidiary of the company, intends to apply for public offering of shares to unspecified qualified investors and listing on the Beijing Stock Exchange. As of the disclosure date of the announcement, Tiankang Bio's public offering of shares to unspecified qualified investors and listing on the North Stock Exchange are under counseling.
Strategy guide
12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14